These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39013991)

  • 1. Rifabutin loaded inhalable β-glucan microparticle based drug delivery system for pulmonary TB.
    Ahmad F; Ahmad S; Upadhyay TK; Singh S; Khubaib M; Singh J; Saeed M; Ahmad I; Al-Keridis LA; Sharma R
    Sci Rep; 2024 Jul; 14(1):16437. PubMed ID: 39013991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
    Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs.
    Cunha L; Rosa da Costa AM; Lourenço JP; Buttini F; Grenha A
    J Microencapsul; 2018 Jun; 35(4):392-405. PubMed ID: 30112917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
    Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
    Sharma R; Saxena D; Dwivedi AK; Misra A
    Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Rifabutin entrapment within glucan microparticles enhances protection against intracellular Mycobacterium tuberculosis.
    Upadhyay TK; Fatima N; Sharma A; Sharma D; Sharma R
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):427-435. PubMed ID: 30672352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.
    Alves AD; Cavaco JS; Guerreiro F; Lourenço JP; Rosa da Costa AM; Grenha A
    Molecules; 2016 May; 21(6):. PubMed ID: 27240337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages.
    Rodrigues S; Cunha L; Rico J; Rosa da Costa AM; Almeida AJ; Faleiro ML; Buttini F; Grenha A
    Drug Deliv Transl Res; 2020 Dec; 10(6):1675-1687. PubMed ID: 32562253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hand-held apparatus for "nose-only" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages.
    Kaur J; Muttil P; Verma RK; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2008 May; 34(1):56-65. PubMed ID: 18387284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.
    Verma RK; Kaur J; Kumar K; Yadav AB; Misra A
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3195-201. PubMed ID: 18591268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytocompatibility and cellular interactions of chondroitin sulfate microparticles designed for inhaled tuberculosis treatment.
    Rodrigues S; Cunha L; Kollan J; Neumann PR; Rosa da Costa AM; Dailey LA; Grenha A
    Eur J Pharm Biopharm; 2021 Jun; 163():171-178. PubMed ID: 33838263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages.
    Upadhyay TK; Fatima N; Sharma D; Saravanakumar V; Sharma R
    EXCLI J; 2017; 16():210-228. PubMed ID: 28507467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
    Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
    J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles.
    Rodrigues S; Alves AD; Cavaco JS; Pontes JF; Guerreiro F; Rosa da Costa AM; Buttini F; Grenha A
    Int J Pharm; 2017 Aug; 529(1-2):433-441. PubMed ID: 28669623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
    Garg T; Goyal AK; Rath G; Murthy RS
    Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages.
    Sharma PR; Dravid AA; Kalapala YC; Gupta VK; Jeyasankar S; Goswami A; Agarwal R
    Biomater Adv; 2022 Feb; 133():112612. PubMed ID: 35527151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.
    Yadav AB; Sharma R; Muttil P; Singh AK; Verma RK; Mohan M; Patel SK; Misra A
    Indian J Exp Biol; 2009 Jun; 47(6):469-74. PubMed ID: 19634713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.